Zobrazeno 1 - 10
of 216
pro vyhledávání: '"A T Masters"'
Autor:
Eliot T. Masters
Publikováno v:
Journal of Ethnobiology and Ethnomedicine, Vol 19, Iss 1, Pp 1-29 (2023)
Abstract Background This paper presents a comparative inventory of medicinal plant taxa and their uses by smallholder farming communities of four cultures in the Aswa River catchment of northern Uganda, situated in the eastern Sudanian savanna parkla
Externí odkaz:
https://doaj.org/article/e42fecd89d84443fa2f4ffb724aa5b8b
Autor:
Eliot T. Masters, Bokary Allaye Kelly
Publikováno v:
International Journal of Food Science, Vol 2024 (2024)
The African locust bean tree Parkia biglobosa (Jacq.) R.Br. ex G. Don is a leguminous species native to the Sudanian parkland of western Africa. The seed obtained from pods collected from trees by rural women is fermented into a dense and aromatic pa
Externí odkaz:
https://doaj.org/article/2a918dbc03fc4337904c87c44d305d68
Autor:
Eliot T. Masters
Publikováno v:
Journal of Ethnobiology and Ethnomedicine, Vol 17, Iss 1, Pp 1-21 (2021)
Abstract Background In the parkland agroforestry system of northern Uganda, smallholder farming households rely on a diversity of plant species to fulfil their nutritional requirements, many of which also serve a range of medicinal, cultural, and liv
Externí odkaz:
https://doaj.org/article/3e6c74d84f004682831d67d7001f11cd
Autor:
David M. Waterhouse, Janet L. Espirito, Marc D. Chioda, Bismark Baidoo, Jack Mardekian, Nicholas J. Robert, Elizabeth T. Masters
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss 4, Pp 261-269 (2020)
Abstract Background Data are sparse concerning the sequential use of multiple anaplastic lymphoma kinase (ALK) inhibitors for ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). Objective This study investigated sequencing
Externí odkaz:
https://doaj.org/article/03f7a6aab37f4777abb0d63f1f78689f
Autor:
Arnold J. Weil, Elizabeth T. Masters, Alexandra I. Barsdorf, Almasa Bass, Glenn Pixton, Jacquelyn G. Wilson, Gernot Wolfram
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-7 (2017)
Abstract Background The efficacy of ALO-02, an abuse-deterrent formulation containing extended-release oxycodone and sequestered naltrexone, in the treatment of chronic low back pain (CLBP) was studied in a 12-week randomized controlled trial. Primar
Externí odkaz:
https://doaj.org/article/918dccc8e1d545fa9ea04368d35bc05b
Autor:
Brett R. Stacey, Jonathan Liss, Regina Behar, Alesia Sadosky, Bruce Parsons, Elizabeth T. Masters, Patrick Hlavacek
Publikováno v:
BMC Health Services Research, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Formularies often employ restriction policies to reduce pharmacy costs. Pregabalin, an alpha-2-delta ligand, is approved for treatment of fibromyalgia (FM); neuropathic pain (NeP) due to postherpetic neuralgia (PHN), diabetic peri
Externí odkaz:
https://doaj.org/article/c8e4941124124ce3aa2c5b4e09e523a8
Autor:
Francesca Kolitsopoulos, Francois-Xavier Lamy, Frank Xiaoqing Liu, Mo Yang, Xinke Zhang, Aziza Jamal-Allial, Elizabeth T. Masters, Daniel C. Beachler, Jade Dinh
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:255-265
BACKGROUND: The treatment landscape for advanced nonsmall cell lung cancer (NSCLC) has evolved from 2015 onward, since the introduction of immune checkpoint inhibitors (ICIs). Considering this shif...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea735eaead62016eea430035de170c4a
https://doi.org/10.18553/jmcp.2021.21216
https://doi.org/10.18553/jmcp.2021.21216
Autor:
Richard W DeClue, Kevin Chin, Lisa Herms, Vivek Pawar, Xinke Zhang, Elizabeth T. Masters, Mo Yang, Vamsidhar Velcheti, Mary Ruisi
Publikováno v:
Immunotherapy. 13:1521-1533
Aim: We report real-world treatment patterns and outcomes in patients with PD-L1+ non-small-cell lung cancer (NSCLC). Methods: This retrospective, observational study using the ConcertAI Oncology Dataset (Symphony AI, CA, USA), included patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35361282b8ee7460345a3f00a86a985a
https://doi.org/10.2217/imt-2021-0145
https://doi.org/10.2217/imt-2021-0145
Autor:
Elizabeth T. Masters, Kinga Marczell, Xinke Zhang, Vivek Pawar, Paulina Kazmierska, Andreas Freitag, Grammati Sarri, Thitima Kongnakorn
Publikováno v:
Pharmacoeconomics
Introduction The introduction of immuno-oncology (IO) therapies has changed the treatment landscape of non-small cell lung cancer (NSCLC). Numerous cost-effectiveness analyses (CEAs) and technology appraisals (TAs) evaluating IO therapies have been r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a53a4b5d69f51856ba010883ce83292a
https://doi.org/10.1007/s40273-021-01089-4
https://doi.org/10.1007/s40273-021-01089-4
Autor:
Lauren J Lee, Christina S Kwon, Carla Mamolo, Elizabeth T. Masters, Anna Forsythe, Ira Jacobs
Publikováno v:
ClinicoEconomics and Outcomes Research. 12:693-709
Purpose Non-muscle invasive bladder cancer (NMIBC) is a malignancy restricted to the inner lining of the bladder. Intravesical Bacillus Calmette-Guerin (BCG) following transurethral resection of the bladder tumor is the mainstay first-line treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e285ed2cf7d30dc6d592196d0e4732c8
https://doi.org/10.2147/ceor.s274951
https://doi.org/10.2147/ceor.s274951